Home/Coare Biotechnology/Edwin Bannerman-Menson
EB

Edwin Bannerman-Menson

CEO, Co-Founder

Coare Biotechnology

Therapeutic Areas

Coare Biotechnology Pipeline

DrugIndicationPhase
DCLK1-Targeted Therapeutic PlatformSolid Tumor Cancers (Pancreatic, Colon, Kidney, Ovarian, Breast)Pre-clinical